|
1
|
Kreth FW, Thon N, Simon M, Westphal M,
Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T,
Weller M, et al: German Glioma Network: Gross total but not
incomplete resection of glioblastoma prolongs survival in the era
of radiochemotherapy. Ann Oncol. 24:3117–3123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bailey P and Cushing H: A classification
of the tumours of the glioma group on a histogenetic basis: With a
correlated study of prognosisMedium 8vo. J.B. Lippincott Company;
Philadelphia, London, and Montreal, with 108 illustrations: pp.
1751926, https://doi.org/10.1002/bjs.1800145540
|
|
3
|
Brennan CW, Verhaak RG, McKenna A, Campos
B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ,
Berman SH, et al: The somatic genomic landscape of glioblastoma.
Cell. 155:462–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hegi ME, Diserens AC, Godard S, Dietrich
PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N and
Stupp R: Clinical trial substantiates the predictive value of
O-6-methylguanine DNA methyltransferase promoter treated
with temozolamide. Clin Cancer Res. 10:1871–1874. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dirks PB and Rutka JT: Current concepts in
neuro-oncology: The cell cycle - A review. Neurosurgery.
40:1000–1013. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stark AM, Doukas A, Hugo HH, Hedderich J,
Hattermann K, Mehdorn Maximilian H and Held-Feindt J: Expression of
DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent
glioblastoma. Neurol Res. 37:95–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roberts SA, Lawrence MS, Klimczak LJ,
Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL,
Saksena G, et al: An APOBEC cytidine deaminase mutagenesis pattern
is widespread in human cancers. Nat Genet. 45:970–976. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wedekind JE, Dance GS, Sowden MP and Smith
HC: Messenger RNA editing in mammals: New members of the APOBEC
family seeking roles in the family business. Trends Genet.
19:207–216. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sheehy AM, Gaddis NC, Choi JD and Malim
MH: Isolation of a human gene that inhibits HIV-1 infection and is
suppressed by the viral Vif protein. Nature. 418:646–650. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Swanton C, McGranahan N, Starrett GJ and
Harris RS: APOBEC enzymes: Mutagenic fuel for cancer evolution and
heterogeneity. Cancer Disc. 5:704–712. 2015. View Article : Google Scholar
|
|
11
|
Burns MB, Lackey L, Carpenter MA, Rathore
A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N,
Nikas JB, et al: APOBEC3B is an enzymatic source of mutation in
breast cancer. Nature. 494:366–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burns MB, Temiz NA and Harris RS: Evidence
for APOBEC3B mutagenesis in multiple human cancers. Nature Genet.
45:977–983. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Broad Institute TCGA Genome Data Analysis
Center: Analysis of mutagenesis by APOBEC cytidine deaminase
(P-MACD). Broad Institute of MIT and Harvard. 2015.doi:
10.7908/C12V2FBX.
|
|
14
|
Held-Feindt J, Hattermann K, Müerköster
SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM
and Mentlein R: CX3CR1 promotes recruitment of human
glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res.
316:1553–1566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hattermann K, Li G, Hugo HH, Mentlein R,
Mehdorn HM and Held-Feindt J: Expression of the chemokines CXCL12
and CX3CL1 and their receptors in human nerve sheath tumors. Histol
Histopathol. 28:1337–1349. 2013.PubMed/NCBI
|
|
16
|
Hattermann K, Holzenburg E, Hans F, Lucius
R, Held-Feindt J and Mentlein R: Effects of the chemokine CXCL12
and combined internalization of its receptors CXCR4 and CXCR7 in
human MCF-7 breast cancer cells. Cell Tiss Res. 357:253–266. 2014.
View Article : Google Scholar
|
|
17
|
Johnson MD, Reeder JE and O'Connell M:
APOBEC3B expression in human leptomeninges and meningiomas. Oncol
Lett. 12:5344–5348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Talagas M, Marcorelles P, Uguen A, Redon
S, Quintin-Roué I, Costa S, Férec C, Morel F, Hieu PD and De
Braekeleer M: Identification of a novel population in high-grade
oligodendroglial tumors not deleted on 1p/19q using array CGH. J
Neurooncol. 109:405–413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Wu S, Zheng S, Wang S, Wali A,
Ezhilarasan R, Sulman EP, Koul D and Yung Alfred WK: APOBEC3G acts
as a therapeutic target in mesenchymal gliomas by sensitizing cells
to radiation-induced cell death. Oncotarget. 8:54285–54296.
2017.PubMed/NCBI
|
|
20
|
Wang YJ, Wang X, Zhang H, Zhou L, Liu S,
Kolson DL, Song L, Ye L and Ho WZ: Expression and regulation of
antiviral protein APOBEC3G in human neuronal cells. J Neuroimmunol.
206:14–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fanourakis G, Tosios K, Papanikolaou N,
Chatzistamou I, Xydous M, Tseleni-Balafouta S, Sklavounou A,
Voutsinas GE and Vastardis H: Evidence for APOBEC3B mRNA and
protein expression in oral squamous cell carcinomas. Exp Mol
Pathol. 101:314–319. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin Z, Han YX and Han XR: The role of
APOBEC3B in chrondosarcoma. Oncol Rep. 32:1867–1872. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leonard B, Hart SN, Burns MB, Carpenter
MA, Temiz NA, Rathore A, Vogel RI, Nikas JB, Law EK, Brown WL, et
al: APOBEC3B upregulation and genomic mutation patterns in serous
ovarian carcinoma. Cancer Res. 73:7222–7231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Olson ME, Harris RS and Harki DA: APOBEC
enzymes as targets for virus and cancer therapy. Cell Chem Biol.
25:36–49. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sasaki H, Suzuki A, Tatematsu T, Shitara
M, Hikosaka Y, Okuda K, Moriyama S, Yano M and Fujii Y:
APOBEC3B gene overexpression in non-small-cell lung cancer.
Biomed Rep. 2:392–395. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Warren CJ, Westrich JA, Doorslaer KV and
Pyeon D: Roles of APOBEC3A and APOBEC3B in human papillomavirus
infection and disease progression. Viruses. 9:pii: E233. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu PF, Chen YS, Kuo TY, Lin HH, Liu CW and
Chang LC: APOBEC3B: A potential factor suppressing growth of human
hepatocellular carcinoma cells. Anticancer Res. 35:1521–1527.
2015.PubMed/NCBI
|
|
28
|
Periyasamy M, Singh AK, Gemma C, Kranjec
C, Farzan R, Leach DA, Navaratnam N, Pálinkás HL, Vértessy BG,
Fenton TR, et al: p53 controls expression of the DNA deaminase
APOBEC3B to limit its potential mutagenic activity in cancer cells.
Nucleic Acids Res. 45:11056–11069. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gomez-Manzano C, Fueyo J, Kyritsis AP,
Steck PA, Roth JA, Mcdonnell TJ, Steck KD, Levin VA and Yung WK:
Adenovirus-mediated transfer of the p53 gene produces rapid
and generalized death of human glioma cells via apoptosis. Cancer
Res. 56:694–699. 1996.PubMed/NCBI
|
|
30
|
Van Meir EG, Kikuchi T, Tada M, Li H,
Diserens AC, Wojcik BE, Huang HJ, Friedmann T, de Tribolet N and
Cavenee WK: Analysis of the p53 gene and its expression in
human glioblastoma cells. Cancer Res. 54:649–652. 1994.PubMed/NCBI
|
|
31
|
Chou WC, Chen WT, Hsiung CN, Hu LY, Yu CJ,
Hsu HM and Shen CJ: B-Myb induces APOBEC3B expression
leading to somatic mutation in multiple cancers. Sci Rep.
7:440892017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maruyama W, Shirakawa K, Matsui H,
Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K
and Takaori-Kondo A: Classical NF-κB pathway is responsible for
APOBEC3B expression in cancer cells. Biochem Biophys Res Comm.
478:1466–1471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leonard B, McCann JL, Starrett GJ,
Kosyakovsky L, Luengas EM, Molan AM, Burns MB, McDougle RM, Parker
PJ, Brown WL, et al: The PKC/NF-κB signaling pathway induces
APOBEC3B expression in multiple human cancers. Cancer Res.
75:4538–4547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nikkilä J, Kumar R, Campbell J, Brandsma
I, Pemberton HN, Wallberg F, Nagy K, Scheer I, Vertessy BG,
Serebrenik AA, et al: Elevated APOBEC3B expression drives a
kataegic-like mutation signature and replication stress-related
therapeutic vulnerabilities in p53-defective cells. Br J Cancer.
117:113–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
